A focus on riociguat in the treatment of pulmonary arterial hypertension-Reference-Cited by-同舟云学术

A focus on riociguat in the treatment of pulmonary arterial hypertension

Published:2019-07-04 Issue:3 Volume:125 Page:202-214
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Toxvig Anne Kathrine¹,Wehland Markus²,Grimm Daniela¹³,Infanger Manfred²,Krüger Marcus²

Affiliation:

1. Department of Biomedicine, Pharmacology Aarhus University Aarhus C Denmark

2. Clinic for Plastic, Aesthetic and Hand Surgery Otto von Guericke University Magdeburg Magdeburg Germany

3. Department of Microgravity and Translational Regenerative Medicine, Faculty of Medicine and Mechanical Engineering Otto von Guericke University Magdeburg Magdeburg Germany

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcpt.13272

Reference55 articles.

1. Riociguat (adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension;Khaybullina D;P T.,2014

2. Updated Clinical Classification of Pulmonary Hypertension

3. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

4. Definitions and Diagnosis of Pulmonary Hypertension

5. Pulmonary arterial hypertension - progress in understanding the disease and prioritizing strategies for drug development

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salidroside enhances NO bioavailability and modulates arginine metabolism to alleviate pulmonary arterial hypertension;European Journal of Medical Research;2024-08-17

2. A Lifelike guided journey through the pathophysiology of pulmonary hypertension—from measured metabolites to the mechanism of action of drugs;Frontiers in Cardiovascular Medicine;2024-05-23

3. Salidroside promotes the eNOS-NO-sGC-cGMP-PKG pathway by correcting arginine metabolism and improves Monocrotaline-induced Pulmonary Arterial Hypertension;2024-05-23

4. Novel drug therapy of acute hepatic failure induced in rats by a combination of tadalafil and Lepidium sativum;BMC Complementary Medicine and Therapies;2024-02-27

5. Decoding signaling mechanisms: unraveling the targets of guanylate cyclase agonists in cardiovascular and digestive diseases;Frontiers in Pharmacology;2023-12-20